Lumenis Ltd., an Israeli medtech company that makes lasers used in eye surgery, urology and cosmetic medical procedures, filed today for an initial public offering worth $115 million. Yokneam, Israel-based Lumenis said it plans to trade on the NASDAQ stock exchange under the “LMNS” symbol. Goldman Sachs, Credit Suisse, Jefferies and Wells Fargo Securities are the joint bookrunners on the offering, according to a regulatory filing.
Help employers find you! Check out all the jobs and post your resume.
